Log In
Print this Print this

VesiculoVax-vectored Ebola virus vaccine

Also known as: VesiculoVax Ebola vaccine

  Manage Alerts
Collapse Summary General Information
Company Profectus BioSciences Inc.
DescriptionRecombinant vesicular stomatitis virus (rVSV)-based vaccine engineered to express the surface protein from the Zaire variant of the Ebola virus
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationEbola
Indication DetailsPrevent Ebola virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today